Form 4: Charles River Labs EVP Victoria Creamer Reports Acquisition of Stock and Options
SEC Form 4
Victoria Creamer, EVP & Chief People Officer at Charles River Laboratories, reports the acquisition of common stock and stock options.
Summary
- On May 31, 2024, Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories International, Inc., acquired 1,967 shares of common stock at $0.
- Following the transaction, Creamer directly owns 14,829 shares of common stock.
- Creamer also acquired 4,470 stock options with an exercise price of $208.44, exercisable starting May 31, 2025, and expiring on May 31, 2034.
- These stock options also vest in installments starting May 31, 2025.
- The report was filed on June 4, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed as a positive signal, but the filing itself is a routine disclosure.
Positives
- The acquisition of stock and options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The acquisition of shares and options by a key executive could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 05/31/2025 | First vesting date for both restricted stock units (491 shares) and stock options (1,117 options). |
| 05/31/2026 | Second vesting date for both restricted stock units (492 shares) and stock options (1,118 options). |
| 05/31/2027 | Third vesting date for both restricted stock units (492 shares) and stock options (1,117 options). |
| 05/31/2028 | Fourth vesting date for both restricted stock units (492 shares) and stock options (1,118 options). |
| 05/31/2034 | Expiration date for the acquired stock options. |
| 06/04/2024 | Date of filing the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.